263 related articles for article (PubMed ID: 31958079)
1. Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo compared to Histology.
Tuzzi E; Balla DZ; Loureiro JRA; Neumann M; Laske C; Pohmann R; Preische O; Scheffler K; Hagberg GE
J Alzheimers Dis; 2020; 73(4):1481-1499. PubMed ID: 31958079
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.
Tiepolt S; Schäfer A; Rullmann M; Roggenhofer E; ; Gertz HJ; Schroeter ML; Patt M; Bazin PL; Jochimsen TH; Turner R; Sabri O; Barthel H
J Alzheimers Dis; 2018; 64(2):393-404. PubMed ID: 29865069
[TBL] [Abstract][Full Text] [Related]
3. Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI.
Gong NJ; Dibb R; Bulk M; van der Weerd L; Liu C
Neuroimage; 2019 May; 191():176-185. PubMed ID: 30739060
[TBL] [Abstract][Full Text] [Related]
4. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
[TBL] [Abstract][Full Text] [Related]
5. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
[TBL] [Abstract][Full Text] [Related]
6. Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study.
Tiepolt S; Rullmann M; Jochimsen TH; Gertz HJ; Schroeter ML; Patt M; Sabri O; Barthel H
Eur J Radiol; 2020 Oct; 131():109243. PubMed ID: 32916411
[TBL] [Abstract][Full Text] [Related]
7. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
[TBL] [Abstract][Full Text] [Related]
8. High resolution anatomical and quantitative MRI of the entire human occipital lobe ex vivo at 9.4T.
Sengupta S; Fritz FJ; Harms RL; Hildebrand S; Tse DHY; Poser BA; Goebel R; Roebroeck A
Neuroimage; 2018 Mar; 168():162-171. PubMed ID: 28336427
[TBL] [Abstract][Full Text] [Related]
9. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
[TBL] [Abstract][Full Text] [Related]
10. In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer's disease.
Kim E; Di Censo D; Baraldo M; Simmons C; Rosa I; Randall K; Ballard C; Dickie BR; Williams SCR; Killick R; Cash D
Sci Rep; 2021 Jun; 11(1):12419. PubMed ID: 34127752
[TBL] [Abstract][Full Text] [Related]
11. Quantitative MRI susceptibility mapping reveals cortical signatures of changes in iron, calcium and zinc in malformations of cortical development in children with drug-resistant epilepsy.
Lorio S; Sedlacik J; So PW; Parkes HG; Gunny R; Löbel U; Li YF; Ogunbiyi O; Mistry T; Dixon E; Adler S; Cross JH; Baldeweg T; Jacques TS; Shmueli K; Carmichael DW
Neuroimage; 2021 Sep; 238():118102. PubMed ID: 34058334
[TBL] [Abstract][Full Text] [Related]
12. Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease.
Kerchner GA
J Alzheimers Dis; 2011; 26 Suppl 3():91-5. PubMed ID: 21971453
[TBL] [Abstract][Full Text] [Related]
13. MR microscopy of human amyloid-β deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid.
Nabuurs RJ; Natté R; de Ronde FM; Hegeman-Kleinn I; Dijkstra J; van Duinen SG; Webb AG; Rozemuller AJ; van Buchem MA; van der Weerd L
J Alzheimers Dis; 2013; 34(4):1037-49. PubMed ID: 23340037
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age.
van Bergen JMG; Li X; Quevenco FC; Gietl AF; Treyer V; Meyer R; Buck A; Kaufmann PA; Nitsch RM; van Zijl PCM; Hock C; Unschuld PG
Neuroimage; 2018 Jul; 174():308-316. PubMed ID: 29548847
[TBL] [Abstract][Full Text] [Related]
15. An MRI-Based Atlas for Correlation of Imaging and Pathologic Findings in Alzheimer's Disease.
Raman MR; Schwarz CG; Murray ME; Lowe VJ; Dickson DW; Jack CR; Kantarci K
J Neuroimaging; 2016 May; 26(3):264-8. PubMed ID: 27017996
[TBL] [Abstract][Full Text] [Related]
16. Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease.
Duarte-Abritta B; Villarreal MF; Abulafia C; Loewenstein D; Curiel Cid RE; Castro MN; Surace E; Sánchez SM; Vigo DE; Vázquez S; Nemeroff CB; Sevlever G; Guinjoan SM
J Psychiatr Res; 2018 Dec; 107():11-18. PubMed ID: 30308328
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.
Snow WM; Dale R; O'Brien-Moran Z; Buist R; Peirson D; Martin M; Albensi BC
J Alzheimers Dis; 2017; 58(3):841-853. PubMed ID: 28505976
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia.
Yu L; Dawe RJ; Buchman AS; Boyle PA; Schneider JA; Arfanakis K; Bennett DA
Behav Brain Res; 2017 Mar; 322(Pt B):233-240. PubMed ID: 27596378
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of amyloid plaques in a mouse model of Alzheimer's disease by phase-contrast X-ray computed tomography.
Noda-Saita K; Yoneyama A; Shitaka Y; Hirai Y; Terai K; Wu J; Takeda T; Hyodo K; Osakabe N; Yamaguchi T; Okada M
Neuroscience; 2006; 138(4):1205-13. PubMed ID: 16460878
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and Prediction of Early Alzheimer's Disease Using a Machine Learning-based Optimized Combination-Feature Set on Gray Matter Volume and Quantitative Susceptibility Mapping.
Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Lee SY; Kim EJ; Wang Y; Jahng GH
Curr Alzheimer Res; 2020; 17(5):428-437. PubMed ID: 32579502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
